Bionano Genomics Inc (BNGO)
0.2218
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 13:15
Bionano Genomics Debt to Equity Ratio: 0.306 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.306 |
| June 30, 2024 | 0.241 |
| March 31, 2024 | 0.3513 |
| December 31, 2023 | 0.7259 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2021 | 0.041 |
| December 31, 2020 | 0.4653 |
| September 30, 2020 | 1.091 |
| June 30, 2020 | 2.692 |
| March 31, 2020 | -4.028 |
| December 31, 2019 | 5.558 |
| September 30, 2019 | -2.674 |
| June 30, 2019 | -14.44 |
| March 31, 2019 | 3.130 |
| December 31, 2018 | 0.8907 |
| September 30, 2018 | 0.5913 |
| June 30, 2018 | -0.4065 |
| March 31, 2018 | -0.3704 |
| December 31, 2017 | -0.134 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-4.028
Minimum
Mar 2020
5.558
Maximum
Dec 2019
0.3722
Average
--
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| Revvity Inc | 0.4023 |
| Bruker Corp | 1.271 |
| Azenta Inc | 0.00 |
| Harvard Bioscience Inc | 0.5796 |
| Akoya Biosciences Inc | 5.568 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 87.36M |
| Total Liabilities (Quarterly) | 38.49M |
| Shareholders Equity (Quarterly) | 48.87M |
| Current Ratio | 1.426 |
| Net Debt Paydown Yield | -7.45% |